Jazz Pharmaceuticals Plc (JAZZ)
247.78
+2.21
(+0.90%)
USD |
NASDAQ |
Sep 03, 12:16
Jazz Pharmaceuticals Research and Development Expense (Annual) : 782.74M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 782.74M |
| December 31, 2024 | 884.00M |
| December 31, 2023 | 849.66M |
| December 31, 2022 | 590.45M |
| December 31, 2021 | 505.75M |
| December 31, 2020 | 335.38M |
| December 31, 2019 | 299.73M |
| December 31, 2018 | 226.62M |
| December 31, 2017 | 198.44M |
| December 31, 2016 | 162.30M |
| December 31, 2015 | 135.25M |
| Date | Value |
|---|---|
| December 31, 2014 | 85.18M |
| December 31, 2013 | 46.62M |
| December 31, 2012 | 20.48M |
| December 31, 2011 | 14.12M |
| December 31, 2010 | 25.61M |
| December 31, 2009 | 36.56M |
| December 31, 2008 | 69.26M |
| December 31, 2007 | 69.79M |
| December 31, 2006 | 54.96M |
| December 31, 2005 | 45.78M |
| December 31, 2004 | 17.99M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Perrigo Co. Plc | 95.40M |
| GH Research Plc | 38.73M |
| Cosmo NV | 36.21M |
| Axsome Therapeutics, Inc. | 182.78M |